• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液系统疾病患者行PICC置管术后血栓形成危险因素分析

Analysis of risk factors for postoperative thrombosis in patients with hematological diseases undergoing PICC surgery.

作者信息

Chang Meifang, Zhu Xiaming, Liu Minghong, Mao Yanqin, Wu Qian

机构信息

Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, China.

出版信息

Medicine (Baltimore). 2025 Jan 10;104(2):e41181. doi: 10.1097/MD.0000000000041181.

DOI:10.1097/MD.0000000000041181
PMID:39792736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11730104/
Abstract

This study analyzes the prognostic factors of thrombosis in patients with hematological diseases after peripherally inserted central catheter (PICC) surgery. We conducted a retrospective analysis of 223 patients with hematological diseases who underwent PICC catheterization between January 2017 and June 2021. These patients were categorized into the thrombotic group and non-thrombotic group based on the occurrence of thrombosis following PICC catheterization. Subsequently, we identified influencing factors for thrombosis in patients with hematological diseases after PICC catheterization using univariate and multivariate logistic regression. Furthermore, we drew the ROC curve and calculated the AUC value to obtain the ideal critical value for predicting thrombosis risk in these patients. After PICC catheterization in 223 patients with hematological tumors, 107 cases developed thrombosis. The univariate analysis revealed significant differences in age, catheter placement, catheter-related complications (infection), the proportion of underlying diseases, and coagulation-related indicators between the 2 groups. Furthermore, the multivariate analysis demonstrated that catheter infection, diabetes, history of thrombosis, fibrinogen degradation products (FDP), antithrombin III (AT-III) and D-dimer were all independent factors of thrombosis in patients with hematological diseases after PICC. The AUC areas of the working characteristic curves of FDP, AT-III, and D-dimer in predicting post PICC thrombosis in patients with hematological diseases were 0.744, 0.651, and 0.595, respectively. Hematological diseases patients with catheter infection, diabetes, history of thrombosis, FDP > 3.24 mg/L, AT-III < 93%, or D-dimer > 2.41 µg/mL are prone to thrombosis after PICC surgery.

摘要

本研究分析血液系统疾病患者经外周静脉穿刺中心静脉置管(PICC)术后血栓形成的预后因素。我们对2017年1月至2021年6月期间接受PICC置管的223例血液系统疾病患者进行了回顾性分析。根据PICC置管后是否发生血栓,将这些患者分为血栓形成组和非血栓形成组。随后,我们采用单因素和多因素logistic回归分析确定血液系统疾病患者PICC置管后血栓形成的影响因素。此外,我们绘制ROC曲线并计算AUC值,以获得预测这些患者血栓形成风险的理想临界值。223例血液系统肿瘤患者PICC置管后,107例发生血栓。单因素分析显示,两组患者在年龄、导管置入部位、导管相关并发症(感染)、基础疾病比例以及凝血相关指标方面存在显著差异。此外,多因素分析表明,导管感染、糖尿病、血栓形成史、纤维蛋白原降解产物(FDP)、抗凝血酶III(AT-III)和D-二聚体均为血液系统疾病患者PICC术后血栓形成的独立因素。FDP、AT-III和D-二聚体预测血液系统疾病患者PICC术后血栓形成的工作特征曲线的AUC面积分别为0.744、0.651和0.595。导管感染、糖尿病、血栓形成史、FDP>3.24mg/L、AT-III<93%或D-二聚体>2.41μg/mL的血液系统疾病患者PICC术后易发生血栓。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa8/11730104/c298e5586a3b/medi-104-e41181-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa8/11730104/e1b70a1cc168/medi-104-e41181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa8/11730104/425f131df529/medi-104-e41181-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa8/11730104/c298e5586a3b/medi-104-e41181-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa8/11730104/e1b70a1cc168/medi-104-e41181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa8/11730104/425f131df529/medi-104-e41181-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa8/11730104/c298e5586a3b/medi-104-e41181-g003.jpg

相似文献

1
Analysis of risk factors for postoperative thrombosis in patients with hematological diseases undergoing PICC surgery.血液系统疾病患者行PICC置管术后血栓形成危险因素分析
Medicine (Baltimore). 2025 Jan 10;104(2):e41181. doi: 10.1097/MD.0000000000041181.
2
Trends in the epidemiology of intravascular device-associated bacteremia among French hematology patients: insights from the SPIADI prospective multicenter study, 2020-2024.法国血液学患者血管内装置相关菌血症的流行病学趋势:来自SPIADI前瞻性多中心研究(2020 - 2024年)的见解
Ann Hematol. 2025 Feb;104(2):1231-1240. doi: 10.1007/s00277-024-06154-4. Epub 2025 Jan 9.
3
Peripherally inserted central catheter design and material for reducing catheter failure and complications.用于减少导管故障和并发症的外周静脉穿刺中心静脉导管的设计与材料
Cochrane Database Syst Rev. 2024 Jun 28;6(6):CD013366. doi: 10.1002/14651858.CD013366.pub2.
4
Prevalence of PICC-related thrombosis in patients with hematological malignancies: a systematic review.血液恶性肿瘤患者经外周静脉置入中心静脉导管相关性血栓形成的发生率:系统评价。
Support Care Cancer. 2024 Jun 26;32(7):462. doi: 10.1007/s00520-024-08636-7.
5
Effect of catheter dwell time on the risk of central line-associated bloodstream infections in central venous catheters and peripherally inserted central catheters.导管留置时间对中心静脉导管和经外周静脉穿刺中心静脉导管相关血流感染风险的影响。
Antimicrob Resist Infect Control. 2025 Jun 20;14(1):70. doi: 10.1186/s13756-025-01590-x.
6
Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis.与经外周静脉置入中心静脉导管相关的静脉血栓栓塞风险:系统评价和荟萃分析。
Lancet. 2013 Jul 27;382(9889):311-25. doi: 10.1016/S0140-6736(13)60592-9. Epub 2013 May 20.
7
Comparison of complication rates between midline catheters and peripherally inserted central catheters: a systematic review and meta-analysis of randomized controlled trials.中线导管与外周静脉置入中心静脉导管并发症发生率的比较:系统评价和随机对照试验的荟萃分析。
J Hosp Infect. 2024 Sep;151:131-139. doi: 10.1016/j.jhin.2024.07.003. Epub 2024 Jul 18.
8
Different diagnostic strategies using D-dimer for peripherally inserted central catheter-related upper extremity deep vein thrombosis.使用D-二聚体诊断外周静脉穿刺中心静脉导管相关上肢深静脉血栓形成的不同策略
J Vasc Surg Venous Lymphat Disord. 2023 May;11(3):565-572. doi: 10.1016/j.jvsv.2022.07.018. Epub 2023 Jan 18.
9
Integrating deep learning in public health: a novel approach to PICC-RVT risk assessment.将深度学习整合到公共卫生领域:一种评估经外周静脉穿刺中心静脉置管相关静脉血栓形成风险的新方法
Front Public Health. 2025 Jan 7;12:1445425. doi: 10.3389/fpubh.2024.1445425. eCollection 2024.
10
Central venous catheter-related thrombosis in patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者的中心静脉导管相关血栓形成
J Vasc Access. 2025 Jul;26(4):1180-1186. doi: 10.1177/11297298241262821. Epub 2024 Aug 1.

本文引用的文献

1
Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype.抗凝血酶缺陷与促血栓形成的血浆纤维蛋白栓子表型相关。
Thromb Haemost. 2023 Sep;123(9):880-891. doi: 10.1055/s-0043-1768712. Epub 2023 May 18.
2
Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.湿发对预防癌症患者化疗所致脱发的作用甚微——荷兰头皮冷却登记研究结果。
Support Care Cancer. 2023 Apr 17;31(5):273. doi: 10.1007/s00520-023-07687-6.
3
A clinical study of peripherally inserted central catheter-related venous thromboembolism in patients with hematological malignancies.
血液病患者经外周中心静脉置管相关静脉血栓栓塞的临床研究。
Sci Rep. 2022 Jun 14;12(1):9871. doi: 10.1038/s41598-022-13916-5.
4
Peripherally inserted central catheter-related bloodstream infections in patients with hematological malignancies: A retrospective 7-years single-center study.血液病患者外周中心静脉置管相关血流感染:一项回顾性的 7 年单中心研究。
Am J Infect Control. 2022 Oct;50(10):1171-1177. doi: 10.1016/j.ajic.2022.01.016. Epub 2022 Jan 30.
5
Upper extremity deep venous thrombosis prevalence in the NHS Grampian Medical Ambulatory clinic: diagnostic, therapeutic, and prognostic considerations in oncology patients.英国国民保健署格兰扁医疗门诊上肢深静脉血栓形成的患病率:肿瘤患者的诊断、治疗和预后考虑因素。
Ir J Med Sci. 2022 Aug;191(4):1569-1575. doi: 10.1007/s11845-021-02775-0. Epub 2021 Sep 13.
6
Oncolytic viruses as a promising therapeutic strategy for hematological malignancies.溶瘤病毒作为血液系统恶性肿瘤有前途的治疗策略。
Biomed Pharmacother. 2021 Jul;139:111573. doi: 10.1016/j.biopha.2021.111573. Epub 2021 Apr 22.
7
A new proactive virtual resource center navigation model identifies patient risk factors to reduce barriers to cancer care during the COVID-19 pandemic.一种新的主动式虚拟资源中心导航模型可识别患者的风险因素,以减少 COVID-19 大流行期间癌症治疗的障碍。
Support Care Cancer. 2021 Oct;29(10):6069-6077. doi: 10.1007/s00520-021-06147-3. Epub 2021 Mar 31.
8
The incidence of asymptomatic thrombosis related to peripherally inserted central catheter in adults: A systematic review and meta-analysis People's.成人外周置入中心静脉导管相关无症状性血栓形成的发生率:系统评价和荟萃分析。
Nurs Open. 2021 Sep;8(5):2249-2261. doi: 10.1002/nop2.811. Epub 2021 Feb 22.
9
Cellular senescence and hematological malignancies: From pathogenesis to therapeutics.细胞衰老与血液系统恶性肿瘤:从发病机制到治疗。
Pharmacol Ther. 2021 Jul;223:107817. doi: 10.1016/j.pharmthera.2021.107817. Epub 2021 Feb 12.
10
The Caprini thrombosis risk model predicts the risk of peripherally inserted central catheter-related upper extremity venous thrombosis in patients with cancer.卡普里尼血栓形成风险模型可预测癌症患者发生经外周静脉穿刺中心静脉置管相关上肢静脉血栓形成的风险。
J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1151-1158. doi: 10.1016/j.jvsv.2020.12.075. Epub 2020 Dec 28.